首页> 外国专利> Modified release Tablets containing amoxicillin and clavulanate potassium

Modified release Tablets containing amoxicillin and clavulanate potassium

机译:含阿莫西林和克拉维酸钾的缓释片

摘要

As a result, the government provided 1900-2600 mg of amoxicillin and a large amount of potassium butyrate, so the ratio between the two components was 2:1-20:1,Every 12 hours and 1 minute, a modified drug release formula, including amoxicillin and potassium butyrate, in the proportion of 2:1 to 20:1, wherein all the formulas of potassium butyrate and the first part of amoxicillin are precursor chemicals acceptable on drugs, allowing immediate release 2. In order to form a direct release phase, amitriptyline, potassium nailing and amitriptyline made of amitriptyline and amoxicillin in the first part, and amoxicillin in the second part made of a pharmaceutically acceptable prosthetic, allowing slow release of amitriptyline in the second part;In order to form a slow release phase, the drug formulation is characterized by the equipment including a direct release formulation, including amoxicillin and potassium bupropionate, and the optional conventional formulation (immediate release), including amoxicillin and slow release formulation Including amoxicillin (without potassium nail).
机译:结果,政府提供了1900-2600 mg的阿莫西林和大量的丁酸钾,因此两种成分之间的比例为2:1-20:1,每12小时1分钟,这是一种改良的药物释放配方,包括比例为2:1至20:1的阿莫西林和丁酸钾,其中丁酸钾的所有分子式和阿莫西林的第一部分都是药物可接受的前体化学品,允许立即释放2。以便形成直接释放阶段,第一部分由阿米替林和阿莫西林制成的阿米替林,钾钉和阿米替林,第二部分由药学上可接受的修复剂制成,阿莫西林在第二部分中制成,允许阿米替林在第二部分缓慢释放;药物制剂的特点是设备包括直接释放制剂(包括阿莫西林和丙酸钾)和可选的常规制剂(立即释放),包括合并阿莫西林和缓释制剂,包括阿莫西林(无钾钉)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号